With More Oversight Possible Under Obama, Drug Industry Works to Polish Its Image

January 9, 2009

The pharmaceutical industry, confronting sluggish growth, low prestige and the prospect of more-aggressive government oversight, is moving on several fronts to burnish its image and align itself rhetorically with the health reform goals of President-elect Barack Obama and the Democratic Congress. (Washington Post)